Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma

NCT04739501 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04739501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04739501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2020
Completion date
March 30, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer